Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy

Clinical trial NCT05276284 · COMPLETED

Trial details

NCT number: NCT05276284
Sponsor: Kristoffer Rohrberg
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Metastatic Cancer

Start date: 2022-09-01
Primary completion: 2024-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.